A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation-Reference-Cited by-同舟云学术

A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation

Published:2018-10 Issue:10 Volume:6 Page:874-883
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Abraham William T.,Kuck Karl-Heinz,Goldsmith Rochelle L.,Lindenfeld JoAnn,Reddy Vivek Y.,Carson Peter E.,Mann Douglas L.,Saville Benjamin,Parise Helen,Chan Rodrigo,Wiegn Phi,Hastings Jeffrey L.,Kaplan Andrew J.,Edelmann Frank,Luthje Lars,Kahwash Rami,Tomassoni Gery F.,Gutterman David D.,Stagg Angela,Burkhoff Daniel,Hasenfuß Gerd

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure;Burkhoff;Am J Physiol Heart Circ Physiol,2005

2. Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration;Lawo;J Am Coll Cardiol,2005

3. Cardiac contractility modulation by non-excitatory currents: studies in isolated cardiac muscle;Brunckhorst;Eur J Heart Fail,2006

4. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure;Borggrefe;Eur Heart J,2008

5. Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration;Neelagaru;Heart Rhythm,2006

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Hospital to Home;JACC: Advances;2024-09

2. HFSA Scientific Statement: Update on Device Based Therapies in Heart Failure;Journal of Cardiac Failure;2024-09

3. Mid-term clinical outcomes and cardiac function in patients receiving cardiac contractility modulation;Journal of Interventional Cardiac Electrophysiology;2024-08-29

4. Genetic cardiomyopathy and significant systolic heart failure treated with cardiac contractility modulation therapy;Heart Rhythm O2;2024-08

5. Nonpharmacological Approaches to Managing Heart Failure With Preserved Ejection Fraction;Circulation: Heart Failure;2024-08